Hutch News

Stories tagged 'acute myeloid leukemia'

Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >


Remembering Dr. Steve Collins

Among 'a lot of brilliant guys,' the leukemia clinician-researcher stood out for his science — and much more

June 2, 2017 | By Mary Engel / Fred Hutch News Service

Dr. Steven J. Collins' research into the molecular genetics of myeloid leukemias changed the way scientists thought about cancer cells and led to the development of one of the earliest targeted therapies.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 20, 2017

Dr. Glenda Gray among Time magazine’s ‘100 most influential’; Fred Hutch license plates coming soon; UW establishes Dr. Oliver W. Press Distinguished MSTP Alumnus Award; and Dr. Vivian Oehler receives ASH Bridge Grant for leukemia research.

View story >


A Q&A with Fred Hutch postdoctoral research fellow Dr. Rachel Perret

As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it

Jan. 9, 2017 | By Rachel Tompa / Fred Hutch News Service

A postdoctoral research fellow training under the mentorship of immunotherapy expert Dr. Phil Greenberg, Dr. Rachel Perret is working toward an “off-the-shelf” version of T-cell therapy.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 21, 2016

Good News: Ceballos honored for public health research; ACS research awards to three Hutch scientists; ASH grant to physician-researcher Halpern; Paulovich facilitates Moonshot panel

View story >


For high-risk leukemia patients, umbilical cord blood transplant associated with lower risk of relapse

Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor

Sept. 7, 2016 | By Rachel Tompa / Fred Hutch News Service

A new study by Fred Hutch researchers, published today in The New England Journal of Medicine, has found that umbilical cord blood transplants may have advantages beyond being an alternative source of stem cells for patients without a traditional donor match. They also are associated with a lower risk of relapse in high-risk leukemia patients.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.